Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Groneberg, D. A.
Right arrow Articles by Fischer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groneberg, D. A.
Right arrow Articles by Fischer, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 30, No. 3, 394-399 (2002)
DOI: 10.1080/01926230252929972

In Vitro Models to Study Hepatotoxicity

David A. Groneberg

Department of Pediatric Pneumology and Immunology, david.groneberg{at}charite.de, Department of Medicine

Christian Grosse-Siestrup

Department of Comparative Medicine and Experimental Animal Sciences, Charité School of Medicine, Humboldt-University Berlin, Germany

Axel Fischer

Department of Pediatric Pneumology and Immunology

Drug discovery and development consists of a series of processes starting with the demonstration of pharmacologica l effects in experimental cell and animal models and ending with drug safety and effi cacy studies in patients. A main limitation is often the unacceptabl e level of toxicity with the liver as the primary target organ. Therefore, approaches to study hepatic toxicity in the early phase of drug discovery represent an important step towards rational drug development. A variety of in vitro liver model s have been developed in the past years. Next to their use in drug development, they can also be applied to study environmental toxins and their hepatotoxicity. The 3 main approache s are ex vivo isolated and perfused organ models, precision-cut liver slices and cell culture models. Although the advantage of whole organ perfusions is based on the assessment of physiologic parameters such as bile production and morphologic parameters such as tissue histology, cell culture models can be effi ciently used to assess cellular metabolism, cytotoxicity and genotoxicity. The advantage of precision-cut liver slices is based on the juxtaposition of cellular assays and tissue morphology. None of these model s can be compared as they all focus on different fi elds of hepatoxicolog y. For the future, the ideal setup for testing the hepatic toxicity of a new compound could of primary studies in cell or slice cultures to assess cellular effects and secondary studies using ex vivo perfused organs to examine gross organ function parameters and histology.

Key Words: Liver • toxicology • liver slices • cell culture • perfusion.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
S. Nagel, O. Hegemann, D. A. Groneberg, and C. Grosse-Siestrup
An Improved Model of Isolated Hemoperfused Porcine Livers Using Pneumatically Driven Pulsating Blood Pumps
Toxicol Pathol, June 1, 2005; 33(4): 434 - 440.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
D. M. Dambach, B. A. Andrews, and F. Moulin
New Technologies and Screening Strategies for Hepatotoxicity: Use of In Vitro Models
Toxicol Pathol, January 1, 2005; 33(1): 17 - 26.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. Grosse-Siestrup, J. Pfeffer, V. Unger, S. Nagel, C. Witt, A. Fischer, and D. A. Groneberg
Isolated Hemoperfused Slaughterhouse Livers as a Valid Model to Study Hepatotoxicity
Toxicol Pathol, October 1, 2002; 30(6): 749 - 754.
[Abstract] [PDF]